Consistent with the in vitro results, restoring the expression of NPTX2 inhibited prostate tumor growth in vivo, demonstrating that NPTX2 is a key inhibitor of tumorigenesis in prostate cancer. The gene discussed is NPTX2; the disease is prostate cancer.